Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 8/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 6/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.60 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.41 |
| ▸ | MC4R | P32245 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | METTL3 | Q86U44 | 1/20 | 0.39 |
| ▸ | RORC | P51449 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.38 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22984272 | 0.85 | CYP2C9 (0.62) | CYP2C9CYP2C19CYP3A4MC4RALDH1A1 | |
| SCHEMBL12294670 | 0.83 | CYP2C9 (0.74) | CYP2C9CYP2C19CYP3A4ALDH1A1POLB | |
| SCHEMBL18642175 | 0.82 | CYP2C9 (0.60) | CYP2C9CYP2C19CYP3A4MC4RALDH1A1 | |
| SCHEMBL22984299 | 0.81 | CYP2C9 (0.58) | CYP2C9CYP2C19CYP3A4MC4RALDH1A1 | |
| SCHEMBL12294770 | 0.81 | CYP2C9 (0.64) | CYP2C9CYP2C19CYP3A4ALDH1A1POLB | |
| SCHEMBL2426016 | 0.80 | CYP2C9 (0.71) | CYP2C9CYP2C19CYP3A4ALDH1A1POLB | |
| SCHEMBL17590053 | 0.80 | CYP2C9 (0.71) | CYP2C9CYP2C19CYP3A4ALDH1A1POLB | |
| SCHEMBL22984314 | 0.80 | CYP2C9 (0.59) | CYP2C9CYP2C19CYP3A4MC4RALDH1A1 | |
| SCHEMBL22984268 | 0.80 | CYP2C9 (0.58) | CYP2C9CYP2C19CYP3A4MC4RALDH1A1 | |
| SCHEMBL22984327 | 0.80 | CYP2C9 (0.58) | CYP2C9CYP2C19CYP3A4MC4RALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10919888-B2 | Benzyl amine-containing heterocyclic compounds and compositions useful against mycobacterial infection | UNIVERSITY OF NOTRE DAME DU LAC (US) | 2021-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10919888-B2 | Benzyl amine-containing heterocyclic compounds and compositions useful against mycobacterial infection | BET1, BRD4, BRD3 | CYP2C9 1631/4885CYP2C19 1458/4885CYP3A4 1325/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.